Clinical Trials for Scott Borinstein

1 Open Trial

Trial TypeProtocol No. &
Open Date
PH 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-MET, in Children With Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.